For example, the use of methotrexate to treat patients with psoriasis is based on that can significant reduce Th1-associated transcription factor T-bet, IL-12 and IFN-γ in serum, and increase Th2-associated GATA3 and IL-4 levels in patients with PASI 75 [36]. This evidence concerns the gene IL4 and psoriasis.